EAM Investors’s Viridian Therapeutics VRDN Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-78,763	Closed	-$2M	–	379
2023 Q1	$2M	Sell	78,763 -20,877	-21%	-$531K	0.39%	109
2022 Q4	$2.91M	Buy	99,640 +45,934	+86%	+$1.34M	0.6%	43
2022 Q3	$1.1M	Buy	+53,706	New	+$1.1M	0.24%	187